MEDREGEN LLC
🇺🇸United States
Clinical Trials
7
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:7
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 2
7 (100.0%)MRG-001 in Patients With Amyotrophic Lateral Sclerosis
Phase 2
Not yet recruiting
- Conditions
- Amyotrophic Lateral SclerosisLou Gehrig DiseaseMotor Neuron DiseaseMotor Neuron Atrophy
- Interventions
- First Posted Date
- 2024-03-18
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- MedRegen LLC
- Target Recruit Count
- 10
- Registration Number
- NCT06315608
MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients
Phase 2
Not yet recruiting
- Conditions
- Cytokine StormAcute Respiratory Distress SyndromeRespiratory FailureRespiratory Distress SyndromeRespiratory Tract Diseases
- Interventions
- Drug: MRG-001 (High-dose)Other: PlaceboDrug: MRG-001 (Low-dose)
- First Posted Date
- 2024-03-13
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- MedRegen LLC
- Target Recruit Count
- 60
- Registration Number
- NCT06308926
MRG-001 in Patients With Alcoholic Hepatitis
Phase 2
Not yet recruiting
- Conditions
- Acute Alcoholic HepatitisAlcoholic Hepatitis
- Interventions
- First Posted Date
- 2024-03-13
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- MedRegen LLC
- Target Recruit Count
- 32
- Registration Number
- NCT06307522
Safety and Efficacy of MRG-001 in Wound Healing in Abdominoplasty Patients
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- MedRegen LLC
- Target Recruit Count
- 10
- Registration Number
- NCT05844527
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients
- First Posted Date
- 2020-11-30
- Last Posted Date
- 2022-02-15
- Lead Sponsor
- MedRegen LLC
- Target Recruit Count
- 40
- Registration Number
- NCT04646603
- Locations
- 🇺🇸
Johns Hopkins Medicine, Baltimore, Maryland, United States
News
No news found